Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$51.18 - $63.75 $1,893 - $2,358
37 Added 44.05%
121 $7.37 Million
Q1 2024

Apr 30, 2024

SELL
$56.55 - $66.59 $961 - $1,132
-17 Reduced 16.83%
84 $4.79 Million
Q4 2023

Jan 31, 2024

BUY
$52.16 - $64.19 $5,268 - $6,483
101 New
101 $6.34 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Naples Money Management LLC Portfolio

Follow Naples Money Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Naples Money Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Naples Money Management LLC with notifications on news.